CBD-Intel

Regulatory trackers

US Regulatory tracker: state regulation of delta-8 THC

Written by || 26th August 2021 || Regulatory trackers | Regulation and Legislation | Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North America North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas United States Utah Vermont Virginia Washington Washington D.C. West Virginia Wisconsin Wyoming

This interactive tracker provides an overview of CBD-Intel’s understanding of delta-8 THC regulation in each state, including links to relevant bills and legislations.

...

Restricted content. Do you want to read more?

Read our latest free content
Resistant legislators deny Kentucky and Tennessee access to medical cannabis
FDA and CDC warnings won’t signal the end of the delta-8 THC market in the US
Delta-8 THC regulation in the US
Beverage brands still searching for the right solution to their drink problem
Could Colombia’s reversal on allowing medical cannabis flower exports impact the global market?
Horse sense or dog trial? The science and law behind CBD petcare products

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions